• Ep 150 [25 September 2024]: Christopher Blanchette PhD MBA – Ready, Set, Launch: Importance of Evidence at Product Launch

  • Sep 26 2024
  • Duración: 57 m
  • Podcast

Ep 150 [25 September 2024]: Christopher Blanchette PhD MBA – Ready, Set, Launch: Importance of Evidence at Product Launch

  • Resumen

  • Ep 150 [25 September 2024]: Christopher Blanchette PhD MBA, Vice President, Clinical Data Science & Evidence, NNI, Novo Nordisk – Our 150th Real-World Wednesdays (RWW): we discussed the importance of meaningful RWE at product launch ("Evidence at Launch") and how trial tokenization as well as other methods support these efforts. In addition, a great perspective on the real-world evidence and epidemiology career path. Please check-out our website to join the club, get updates and see podcast recordings: https://rwd-rwe.club Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.

    Más Menos
activate_Holiday_promo_in_buybox_DT_T2

Lo que los oyentes dicen sobre Ep 150 [25 September 2024]: Christopher Blanchette PhD MBA – Ready, Set, Launch: Importance of Evidence at Product Launch

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.